Compositions and methods for prophylaxis and therapy for meniere's disease

A method comprising administering to an individual diagnosed with Meniere's Disease a pharmaceutical composition comprising an effective amount of lamotrigine or a pharmaceutically acceptable salt thereof such that the effective amount of the lamotrigine or the pharmaceutically acceptable salt thereof is sufficient to reduce dizziness that is caused by the Meniere's Disease in the individual, wherein the lamotrigine or the pharmaceutically acceptable salt thereof is the only bioactive compound in the pharmaceutical composition that is effective to treat the dizziness caused by the Meniere's Disease, wherein the individual is also diagnosed with phobic postural vertigo and/or chronic subjective dizziness, the method further comprising administering to the individual a pharmaceutical composition comprising an effective amount of bupropion or a pharmaceutically acceptable salt thereof such that the phobic postural vertigo and/or chronic subjective dizziness is also reduced.